Neoadjuvant Toripalimab in Combination with Gemcitabine and Cisplatin Therapy in Local Advanced Bladder Cancer Subjects

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 3, 2021

Primary Completion Date

October 3, 2026

Study Completion Date

April 3, 2027

Conditions

Urinary Bladder Cancer

Interventions

DRUG

Neoadjuvant Toripalimab in Combination With Gemcitabine and Cisplatin

4 cycle neoadjuvant therapy and radical cystectomy

Trial Locations (1)

RECRUITING

Zhujiang Hospital, Guangzhou

All Listed Sponsors

lead

Zhujiang Hospital

OTHER